Regional lymph node metastasis is a powerful predictor of decreased overall
survival from malignant melanoma. However, the therapeutic value of electi
ve node dissections and the role of adjuvant therapy for node-positive dise
ase have been highly controversial. Sentinel lymph node biopsy has reshaped
the debate by allowing for staging of the regional lymph nodes with less m
orbidity and greater accuracy. This review summarizes the current consensus
on the management of node-positive melanoma in the era of sentinel lymph n
ode biopsy. (C) 2001 Elsevier Science Ltd. All rights reserved.